Company Filing History:
Years Active: 2017-2024
Title: Christian Wehrey: Innovator in Pharmaceutical Chemistry
Introduction
Christian Wehrey is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes for synthesizing complex compounds. With a total of 2 patents to his name, Wehrey continues to push the boundaries of chemical research.
Latest Patents
Wehrey's latest patents include a novel process for the preparation of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate. This process involves a Suzuki coupling of a specific compound with an organoboron reagent, showcasing his expertise in advanced synthetic methodologies. Another significant patent is for preparing 4-(cyclopropylmethoxy)-N-(3,5-dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide. This invention relates to a novel process that includes several synthetic intermediates useful in the preparation of this compound.
Career Highlights
Christian Wehrey is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on innovative drug development and contribute to the advancement of pharmaceutical sciences. His expertise in chemical synthesis has been instrumental in the development of new therapeutic agents.
Collaborations
Wehrey has collaborated with several esteemed colleagues, including Jean-Paul Casimir and Guy Rossey. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Christian Wehrey is a prominent figure in pharmaceutical chemistry, with a focus on innovative synthesis processes. His contributions through patents and collaborations highlight his commitment to advancing the field. His work continues to impact the development of new pharmaceuticals, making him a valuable asset to the scientific community.